Breast cancers with the common ERBB2 amplification defining the HER2-positive subset have only partially overlapping amplifications with CTCFL suggesting that the two amplicons may be created by different underlying mechanisms and not by a common mechanism affecting the two chromosomes, 17 and 20. Here, ERBB2 is linked to breast carcinoma.